>>BOSTON--(BUSINESS WIRE)--Nov. 13, 2001--
Strengthens position as a leading global provider of drug discovery tools
Adds automated liquid handling, sample preparation and biochip technologies
PerkinElmer, Inc. (NYSE:PKI - news), a leading provider of life sciences solutions, today successfully completed its acquisition of Packard BioScience Company, a global leader in drug discovery tools. The acquisition extends PerkinElmer's capabilities in automated liquid handling and sample preparation, and strengthens the company's position as a global provider of comprehensive drug discovery solutions.
Packard BioScience will be integrated with PerkinElmer's Life Sciences business, under the leadership of John J. Engel, president of Life Sciences and executive vice president of PerkinElmer, Inc. Dr. Frank Witney, formerly president of Packard BioScience, has been appointed as president of Drug Discovery, reporting to Engel.
``Packard's strength in liquid handling and automated sample preparation products, combined with PerkinElmer's instrumentation and reagent depth, will allow us to offer the full spectrum of drug discovery tools,'' said Engel. ``The combined company will be well-positioned to address the emerging biochip and microarray markets with their combined technologies, including consumables, instrumentation and informatics software.''<<
snip
Cheers, Tuck |
